Skip to main content

Education

M.A., economics, University of British Columbia; B.A., socio-political economics, Boston University; Advanced Program in Transition Economics, CERGE, Prague, CZ

Summary

Mr. White is a consulting economist who specializes in applying microeconomics and sophisticated econometric modeling to complex litigation and merger-related questions, primarily in matters involving the health care, financial services, and technology industries. His work across a diverse set of engagements has encompassed simulating consumer demand and switching behavior, analyzing whether intellectual property (IP) licensing rates are FRAND-compliant, and estimating ex ante default probabilities for structured investment vehicles. He also has substantial experience developing innovative technological tools for analyzing datasets for merger and competition analyses.

Mr. White has supported both economic and scientific experts addressing competition and intellectual property (IP) issues in matters related to cutting-edge pharmaceutical products. He has supported clients in various jurisdictions and industries in follow-on cartel damages litigation, assessing overcharge, upstream and downstream pass-on, and volume effects.

Mr. White has worked in a number of international jurisdictions and has served as a testifying expert in the UK’s Upper Tribunal (Lands Chamber) on competition matters related to restrictive land covenants. He has also given evidence and submissions to the UK’s Competition and Markets Authority (CMA) on behalf of clients involved in market investigations and mergers. Mr. White has supported several clients before the European Commission on cartel and merger matters and has provided support to European financial and competition regulators in coordinated conduct investigations. Mr. White has published a number of articles and regularly speaks at international competition law and policy conferences.

Selected Cases & Publications

Evolving Approaches to Pharmaceutical Competition: Navigating UK and EU Policy Shifts

Pharmaceutical firms operating in the UK and EU face unique scrutiny due to national differences in regulatory frameworks, enforcement approaches, and market structures. The increasingly complex interplay between regulation, innovation, and industry dynamics has led the European Commission and other regulators to advance novel theories of harm in their reviews of pharmaceutical transactions. 

...

Read More

Sika AG Acquisition of MBCC Group

Analysis Group was retained on behalf of Sika AG, a specialty chemicals company, in connection with its intended acquisition of MBCC, a global supplier of construction chemicals.

Read More

Associated People

Joshua White
Joshua White

Mission Impossible? Teresa Ribera’s Mission Letter and the Future of EU Merger Review

Kluwer Competition Law Blog, 2024
Read More

Associated People

Joshua White
Joshua White

Meta’s Response to EU Order Re: Data Transfers

On behalf of Meta, an Analysis Group team developed a white paper assessing the possible economic impacts of data transfers between Europe and the US in the wake of the Court of Justice of the European Union’s Schrems II decision. 

Read More

Associated People

Joshua White
Joshua White

Global Issues In EU's Licensing Plans For Essential Patents

Law360.com, June 1, 2023
Read More

Associated People

Joshua White
Joshua White

Veolia/Suez Merger Approval

On behalf of Suez in its acquisition by the international environmental services conglomerate Veolia, Analysis Group teams provided economic and financial analyses for review by regulatory agencies in multiple countries.

Read More

LVMH Moet Hennessy-Louis Vuitton SE Acquisition of Tiffany & Co.

For the proposed acquisition of global luxury jeweler Tiffany & Co. by LVMH Moët Hennessy Louis Vuitton SE (LVMH), an Analysis Group team led provided economic analysis in support of securing merger approval from competition authorities across nine countries and the European Union.

Read More

Access to big data as a remedy in big tech

Competition Law Journal, 2021
Read More

Associated People

Joshua White
Joshua White

Economics – Overview

Global Competition Review: Europe, Middle East and Africa Antitrust Review 2020, July 2019
Read More

Associated People

Joshua White
Joshua White

Economics of Excessive Pricing: An Application to the Pharmaceutical Industry

Journal of European Competition Law & Practice, February 22, 2019
Read More

European Union – Two-Sided Markets, Platforms and Network Effects

Global Competition Review, E-Commerce Competition Enforcement Guide, January 2019
Read More

Competitive assessment of digital comparison platforms: In search of consensus

Concurrences No. 3, 2018
Read More

Associated People

Joshua White
Joshua White

Economics – Overview

Global Competition Review, The European, Middle Eastern, and African Antitrust Review 2019, 27 June 2018
Read More

Associated People

Joshua White
Joshua White

Related News

  • Analysis Group Authors Examine Pharmaceutical Industry Competition Policy Developments Across Europe
    Read More
  • Analysis Group Congratulates Authors of Five Articles Distinguished with Nominations for 2025 Concurrences Antitrust Writing Awards
    Read More
  • Analysis Group Authors Explore the Future of EU Merger Review Policy
    Read More
  • Vice President Joshua White Explores the Choice, Design, and Implementation of Merger Remedies at Concurrences Event
    Read More
  • Vice President Josh White Hosts Fireside Chat and Panel at “GCR & Analysis Group: Competition and Sustainability 2023”
    Read More
  • Vice President Joshua White Outlines Critical Considerations for Pharmaceutical Industry Mergers at Concurrences Event
    Read More
  • Patent Experts from Analysis Group Examine Proposed Competence Center for Standard Essential Patents (SEPs) in Europe
    Read More
  • Five Analysis Group Articles Nominated for the 2022 Concurrences Antitrust Writing Awards
    Read More
/

Related Events

  • Vice President Joshua White to Join Technology Mergers Panel at GCR Live
    Read More
  • Managing Principal Antoine Chapsal and Vice President Joshua White to Join Panels at Concurrences’ Third Annual International Mergers Conference
    Read More
  • Vice President Joshua White to Join a Panel at Concurrences’ Fourth International Mergers Conference
    Read More
  • Principal Chris Feige to Discuss Securities Class Actions at Annual Symposium
    Read More
  • Vice President Josh White to Join a Panel at Concurrences’ Fifth International Mergers Conference
    Read More
  • Vice President Joshua White to Discuss Emerging Tensions Between Antitrust Law and Efforts to Promote Carbon Reductions in ABA Webinar
    Read More
  • Vice President Joshua White to Join Panel on the Future of Competition Law in Pharma and Tech at ABA Conference
    Read More
  • Vice President Joshua White to Join ABA Webinar on Sustainability Trends in Merger Reviews
    Read More
/